Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567
Anindya Bhattacharya, Qi Wang, Hong Ao, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 3, pp. 624-640
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Rachael Bartlett, Leanne Stokes, Ronald Sluyter
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 638-675
Open Access | Times Cited: 360
P2X7 receptor: an emerging target in central nervous system diseases
Beáta Sperlágh, Péter Illés
Trends in Pharmacological Sciences (2014) Vol. 35, Iss. 10, pp. 537-547
Open Access | Times Cited: 347
The P2X7 receptor: A main player in inflammation
Elena Adinolfi, Anna Lisa Giuliani, Elena De Marchi, et al.
Biochemical Pharmacology (2017) Vol. 151, pp. 234-244
Open Access | Times Cited: 325
Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa, Toshimitsu Kawate
eLife (2016) Vol. 5
Open Access | Times Cited: 260
Medicinal chemistry of adenosine, P2Y and P2X receptors
Kenneth A. Jacobson, Christa E. Müller
Neuropharmacology (2015) Vol. 104, pp. 31-49
Open Access | Times Cited: 241
The P2X7 Receptor
Ronald Sluyter
Advances in experimental medicine and biology (2017), pp. 17-53
Closed Access | Times Cited: 191
Neuroimmune signaling in alcohol use disorder
Emma K. Erickson, Emily K. Grantham, Anna S. Warden, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 177, pp. 34-60
Open Access | Times Cited: 187
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Anindya Bhattacharya, Knut Biber
Glia (2016) Vol. 64, Iss. 10, pp. 1772-1787
Closed Access | Times Cited: 178
P2X receptors
R. Alan North
Philosophical Transactions of the Royal Society B Biological Sciences (2016) Vol. 371, Iss. 1700, pp. 20150427-20150427
Open Access | Times Cited: 164
The role of microglial P2X7: modulation of cell death and cytokine release
Yingbo He, Natalie Taylor, Lawrence Fourgeaud, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 152
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy
Alba Jimenez‐Pacheco, Miguel Dı́az-Hernández, Marina Arribas-Blázquez, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 22, pp. 5920-5932
Open Access | Times Cited: 142
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara, Elena Adinolfi, Catherine Α. Harwood, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 136
Purinergic system in psychiatric diseases
Arquimedes Cheffer, Ana Regina Geciauskas Lage Castillo, Juliana Corrêa-Velloso, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 1, pp. 94-106
Closed Access | Times Cited: 127
The P2X7 Receptor: Central Hub of Brain Diseases
Roberta Andrejew, Ágatha Oliveira‐Giacomelli, Deidiane Elisa Ribeiro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 115
Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosis
Savina Apolloni, Susanna Amadio, Chiara Parisi, et al.
Disease Models & Mechanisms (2014)
Open Access | Times Cited: 114
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Robin Ortiz, Henning Ulrich, Carlos A. Zarate, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 57, pp. 117-131
Open Access | Times Cited: 112
Central nervous system myeloid cells as drug targets: current status and translational challenges
Knut Biber, Thomas Möller, Erik Boddeke, et al.
Nature Reviews Drug Discovery (2015) Vol. 15, Iss. 2, pp. 110-124
Closed Access | Times Cited: 104
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102
microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus
Eva M. Jiménez‐Mateos, Marina Arribas-Blázquez, Amaya Sanz‐Rodriguez, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 99
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 99
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Edward Beamer, Flóra Gölöncsér, Gergely Horváth, et al.
Neuropharmacology (2015) Vol. 104, pp. 94-104
Open Access | Times Cited: 91
Microglial pannexin-1 channel activation is a spinal determinant of joint pain
Michael Mousseau, Nicole E. Burma, Kwan Yeop Lee, et al.
Science Advances (2018) Vol. 4, Iss. 8
Open Access | Times Cited: 86
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
Kasper Recourt, Peter de Boer, Peter van der Ark, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy
Chiara Bianca Maria Platania, Francesca Lazzara, Kenneth P. Mitton, et al.
British Journal of Pharmacology (2025)
Open Access | Times Cited: 1
ATPergic signalling during seizures and epilepsy
Tobías Engel, Mariana Alves, Caroline Sheedy, et al.
Neuropharmacology (2015) Vol. 104, pp. 140-153
Closed Access | Times Cited: 87
Page 1 - Next Page

Scroll to top